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Daily cyclical expression of thousands of genes in tissues such as the
liver is orchestrated by the molecular circadian clock, the disruption
of which is implicated in metabolic disorders and cancer. Although
we understand much about the circadian transcription factors that
can switch gene expression on and off, it is still unclear how global
changes in rhythmic transcription are controlled at the genomic
level. Here, we demonstrate circadian modiﬁcation of an activating
histone mark at a signiﬁcant proportion of gene loci that undergo
daily transcription, implicating widespread epigenetic modiﬁcation
as a key node regulated by the clockwork. Furthermore, we identify
the histone-remodelling enzyme mixed lineage leukemia (MLL)3 as
a clock-controlled factor that is able to directly and indirectly mod-
ulate over a hundred epigenetically targeted circadian “output”
genes in the liver. Importantly, catalytic inactivation of the histone
methyltransferase activity of MLL3 also severely compromises the
oscillation of “core” clock gene promoters, including Bmal1,mCry1,
mPer2, and Rev-erbα, suggesting that rhythmic histonemethylation
is vital for robust transcriptional oscillator function. This highlights
a pathway by which the clockwork exerts genome-wide control
over transcription,which is critical for sustaining temporal program-
ming of tissue physiology.
epigenomics | systems biology
The molecular clockwork consists of well-characterized tran-scriptional components [including Clock, brain and muscle
aryl hydrocarbon receptor nuclear translocator (ARNT)-like
(Bmal) 1, Period, Cryptochrome, and nuclear receptor subfamily
1, group D, member 1/2 (Rev-erbα/β)], as well as more recently
discovered posttranscriptional processes (1–4). Despite progress
in understanding the make up of circadian transcriptomes and
proteomes, which are thought to encompass more than 10% of
known genes and proteins, the systems-level mechanisms driving
their rhythmic abundance have remained unclear (5–7).
Based on observations that a few speciﬁc clock-regulated ge-
nomic loci undergo changes in chromatin state over the circadian
cycle (8–10), we hypothesized that this might be more generally
applicable at other clock-controlled gene (CCG) loci. We in-
vestigated this by performing chromatin immunoprecipitation
(ChiP) and high-throughput sequencing (ChIP-seq) on mouse
liver tissue collected over the circadian cycle to delineate global
changes in the epigenome over a 24-h time frame.
Results and Discussion
We focused mostly on the activation mark, H3K4me3 (histone
H3 trimethylated at lysine 4) (11), which exhibited a clear cir-
cadian proﬁle at thousands of genomic loci (Fig. 1 A and B). This
was in stark contrast to H3K9me3 (histone H3 trimethylated at
lysine 9), which is associated with transcriptional inhibition (12),
and unmodiﬁed histone H3, the binding of which changed only
at relatively few loci (Fig. 1A). Therefore, genomic scale changes
in the evolutionarily conserved activation mark H3K4me3 are
regulated in a circadian manner at thousands of gene loci.
We next examined the relevance of these pervasive changes for
rhythmic gene expression. Initially, we cross-correlated rhythmic
H3K4me3-binding sites with genes that had been shown pre-
viously to be rhythmic by high-resolution gene expression pro-
ﬁling (7). This revealed that 23% (887/3821) of rhythmically
methylated loci were associated with circadian transcription pat-
terns (SI Appendix, Table S1 and Fig. S1A). To conﬁrm these
ﬁndings, in the same liver sample set used for the ChIP-seq
experiments, we performed expression proﬁling with a different
microarray platform and found that these transcripts also oscil-
lated in three biological replicates per time point (Fig. 1C and SI
Appendix, Table S2). At the genomic scale, loci that did not un-
dergo rhythmic histone modiﬁcation were 3.16-fold (95% conﬁ-
dence interval, 2.94–3.40) less likely to exhibit circadian transcription
(χ2 = 997.2; P < 0.0001; SI Appendix, Fig. S2). Thus, rhythmic
histone modiﬁcation over the circadian day and night is highly
associated with rhythmic gene expression. Interestingly, however,
there was no obvious relationship between the H3K4me3 mark
being more prevalent at circadian time (CT)18 and the number
of transcripts peaking at that particular time point compared
with others (SI Appendix, Fig. S1B).
To determine the mechanisms by which circadian changes in
histone H3 methylation might be brought about, we assayed the
expression of components of the activating signal cointegrator-2
like complex, which facilitates trimethylation of H3K4 (13). Only
the histone methyltransferase mixed lineage leukemia 3 (MLL3)
showed rhythmic abundance over the circadian cycle, with peak
expression at the end of the rodents’ inactive phase (Fig. 2A).
This was mirrored by changes in MLL3 protein abundance,
which was clearly disrupted in mCryptochrome (mCry) 1/2 dou-
ble-knockout livers (14), illustrating that MLL3 rhythmicity is
dependent on a functional transcriptional clock (Fig. 2B). Thus,
MLL3 is a clock-controlled factor that could potentially regulate
the circadian epigenomic and transcriptional proﬁles we observed.
To test this, we determined MLL3-binding sites across the
genome, using the same samples that we used for our histone H3
analysis. At rhythmic H3K4me3 loci that generated circadian
transcripts, MLL3 was bound at 12% (460/3821) of transcription
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start sites (Fig. 2C and SI Appendix, Table S3 and Fig. S3). Fur-
thermore, comparison of MLL3 binding and H3K4 methylation
at the genomic scale, using DiffBind (15), revealed substantial
cross-correlation (Fig. 2D). Interestingly, although the genomic
distribution of H3K4me3 sites remained similar over the circa-
dian cycle, there was a sizeable shift of MLL3-binding sites to
intergenic regions at the end of the circadian night, which may
be relevant for the regulation of noncoding RNA expression
(SI Appendix, Fig. S4). These data, thus, imply that MLL3 is
rhythmically bound at epigenetically regulated circadian loci in
the liver.
To dissect mechanism further, and speciﬁcally show that
methyltransferase activity of MLL3 is important for generating
the transcriptional changes that we observe, we performed fur-
ther ChIP-seq experiments with transgenic mouse embryonic
ﬁbroblasts (MEFs) from mice harboring a mutant (catalytically
inactive) form of MLL3. At the genomic scale, catalytic in-
activation of MLL3 in the MLL3Δ/Δ cells had a major impact,
resulting in loss of trimethylation of H3K4 at thousands of loci
(Fig. 3A). Moreover, in these cells, there was arrhythmic, but
augmented, MLL3 binding at loci that were rhythmically bound
in wild-type (MLL3+/+) cells sampled at the same time point after
cell synchronization (Fig. 3A). One intriguing possibility is that
this rather widespread loss of trimethylation results from a dom-
inant-negative effect of the MLL3Δ/Δ allele upon other cognate
methyltransferases. With this in mind we, ﬁltered for MLL3-
speciﬁc methylation by only focusing on loci that, having been
methylated in wild types, became unmethylated inMLL3Δ/Δ cells.
This ﬁltered set of regions was then mapped back on to our liver
cistromic datasets to reciprocally determine expression proﬁles for
these loci, assuming that these would be similarly regulated in liver
tissue. We, thus, found that 13% (119/887) of rhythmically meth-
ylated genes are likely to be directly regulated by MLL3 (SI Ap-
pendix, Table S4). Functional analysis of these MLL3-regulated
genes revealed some interesting targets including S-adenosyl
homocysteine hydrolase and peroxiredoxin 6 (Prdx6), both of which
are characterized clock-controlled genes in the liver (5, 16) (SI
Appendix, Table S5). In particular, S-adenosyl homocysteine hy-
drolase is essential for adequate removal of S-adenosyl homo-
cysteine (SAH), which is a product ofmethyltransferases (including
MLL3) that use S-adenosyl methionine as a methyl donor for their
reactions (17). Accumulation of SAH inhibits enzyme activity (18).
Thus, hydrolase activity removes product inhibition by SAH, which
is essential for maintenance of methyltransferase activity. In ad-
dition, functionally related components in the one-carbon pathway
are also MLL3-regulated circadian genes (SI Appendix, Fig. S5),
suggesting that MLL3 regulates the availability of methyl groups,
which is essential for its own function, as well as for that of other
methyltransferase enzymes. Importantly, this regulation is de-
pendent on the liver clock, rather than on systemic (19) or feeding-
related (20) cues (SI Appendix, Tables S6 and S7).
Given that MLL3 activity had an impact on the expression of a
large number of clock-controlled genes, we investigated whether
it might also inﬂuence the rhythmicity of components of the
“core” transcriptional machinery, namely Reverb-α (Nr1d1),
mPeriod (mPer) 1, mPer2, mCry1, mCry2, and Bmal1. Chromatin
state maps of their genomic loci displayed circadian variation in
H3K4me3 levels, suggesting further that MLL3 could potentially
affect their expression, either directly or indirectly (Fig. 4A). To
probe this further, we made stable bioluminescent MEF reporter
cell lines that gave real-time readouts of transcriptional activa-
tion at each clock gene’s promoter region. Following synchro-
nization with dexamethasone, we sampled wild-type (MLL3+/+)
and catalytically inactive (MLL3Δ/Δ) cells, monitoring promoter
activity for at least 5 d in the absence of external time cues (that
is, under “constant conditions”) (Fig. 4B). In all reporter lines,
there was a stark difference between the genotypes, with robust
reporter expression in wild types, but severely compromised
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Fig. 1. Circadian cycling of chromatin marks at promoter regions in mouse liver. (A) Whole-genome cycling of activating (H3K4me3) and inhibitory
(H3K9me3) chromatin marks but not unmodiﬁed histone H3, over the circadian day and night. Data are double-plotted for clarity. Light gray bars indicate
circadian daytime; black bars signify circadian night. (B) Heat map of H3K4me3 binding signal at CT0 to CT18 (with CT0 replotted), from –5 kb to +5 kb
surrounding the center of all coding gene loci. ChIP-seq with anti-H3K4me3 antiserum was performed, and data were analyzed as described in SI Appendix.
Each line represents a single H3K4me3-binding region. CT, circadian time (animals maintained in constant darkness, with subjective dawn represented by CT0,
and dusk represented by CT12). The input (nonenriched) DNA signal at the same locus is shown for comparison. (C) Heat map of genes exhibiting circadian
expression that also undergo rhythmic change in H3K4me3 binding at their promoter regions. Normalized expression is shown for three independent bi-
ological replicate sets of liver, sampled every 3 h in constant conditions.
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transcriptional output in the MLL3Δ/Δ MEFs. These ﬁndings are
echoed by data from a recent RNA inference screen for circadian
modiﬁers in human cells (SI Appendix, Fig. S6) (21). Corre-
spondingly, temporal patterning of precursor mRNA (pre-mRNA)
and mature mRNA in MLL3Δ/Δ cells was clearly different to that
seen in MLL3+/+ MEFs (Fig. 4C). Lack of MLL3 methyl-
transferase activity, thus, signiﬁcantly disrupts “clock gene” tran-
scriptional activity (Fig. 4 B and C), as well as its own expression
(SI Appendix, Fig. S7), implying that MLL3 plays an important role
in controlling both core and “output” genes associated with the
transcriptional clockwork.
Together, our ﬁndings strongly support the idea that daily
changes in chromatin architecture at the genomic scale take place
in mammalian tissue and that almost a ﬁfth of circadian gene
expression in the liver is associated with variation of a single ac-
tivating chromatin mark (H3K4me3). A signiﬁcant proportion of
these changes, resulting in rhythmic transcription at the systems
level, can be attributed to MLL3 activity. Whereas 13% of these
transcriptional changes might be direct effects of rhythmic MLL3-
dependent histone methylation at the loci in question, the re-
mainder might possibly be an indirect effect of the action of
MLL3 upon transcription of core clock genes and other methyl-
transferases. In contrast to the recently described role played by
another trithorax-group methyltransferase, MLL1, in modulating
speciﬁc Clock-bound genomic loci (9), our data suggest that
recruitment of MLL3 does not require Bmal1 (SI Appendix, Fig.
S8) (22) and, therefore, nor its heterodimerization partner Clock,
supporting a complementary and independent mechanism of
action. This is consistent with the fact that MLL1 and MLL3 form
mutually exclusive complexes to modulate chromatin state, with
differing constituents (23). It is increasingly apparent that the
temporal phasing between chromatin modiﬁcations and tran-
scription will depend on multiple inﬂuences and that a combina-
torial assessment of these phenomena is required to dissect these
factors more fully (24), as well as disentangling the importance of
posttranscriptional and posttranslational processes in sculpting
circadian mRNA and protein proﬁles (1, 5, 25). Because mis-
regulation of MLL3 activity is associated with multiple cancers
(26–28), and our data link its function to the competency of the
core transcriptional clockwork and its downstream effectors, this
provides a framework to understand the role of MLL3, histone
methylation, and the circadian clock in maintaining normal tissue
physiology, and in pathologies such as cancer.
Materials and Methods
ChIP. All animal experimentation was licensed by the Home Ofﬁce under the
Animals (Scientiﬁc Procedures) Act, 1987, and was reviewed by the University
of Cambridge Local Ethical Review committee. Liver tissue was harvested
from n = 4 adult male C57BL/6 mice once every 3 h on the second cycle after
transfer from 12L:12DR to 12DR:12DR (L, light [220 μW·cm−2] and DR, dim
red light [<5 μW·cm−2]) and immediately frozen and then stored at −80 °C
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Fig. 2. MLL3 is a circadian factor that binds to the genome rhythmically. (A) Expression of MLL3 (and the control gene, Bmal1) in mouse liver over the
circadian cycle. Data are means ± SEM for three biological replicate liver samples per time point. (B) Abundance of MLL3 (and Bmal1) protein in wild-type and
cryptochrome-deﬁcient (mCry1/2−/−) mouse livers sampled over the day and night. Immunoblots representative of at least three independent time courses are
shown. β-Actin blots are shown as gel loading controls. (C) Heat maps showing H3K4me3- and MLL3-binding signal at hundreds of promoter regions, from –5
kb to +5 kb surrounding the center of each binding site. Each line represents an H3K4me3 site and MLL3-binding region. CT, circadian time (animals
maintained in constant darkness, with subjective dawn represented by CT0, and dusk represented by CT12). The input (nonenriched) DNA signal at the same
locus is shown for comparison. (D) Heat map representing MLL3-binding events compared with those of H3K4me3. For each of the differentially bound sites,
the reads per kilobase per million mapped reads (RPKM)-fold (RPKM of ChIP divided by RPKM of control) was calculated for each sample, and a Pearson
correlation value for each sample pair computed. The heat map shows the correlation scores.
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before use. Before sampling, animals were stably entrained to a 12-h L:12-h
DR cycle for 3–4 wk. Liver tissue (30 mg per ﬁnal ChIP) was rapidly chopped
into small (approximately 5 × 5 × 2.5 mm3) while defrosting using a sterile
scalpel and immediately submerged in 4% (wt/vol) formaldehyde (Sigma)
and incubated at room temperature with gentle shaking for 10 min. Glycine
(1.25 M) was added to a ﬁnal concentration of 125 mM and incubated for
a further 10 min to quench the formaldehyde. Tissue was then dounce-ho-
mogenized brieﬂy to break up the tissue and then passed through a 100-μm
cell strainer (BD Biosciences), and a cell suspension was harvested. The cells
were washed in ice-cold PBS and then incubated with 2 mL of Farnham lysis
buffer at 4 °C for 15 min to release nuclei. After spinning down, pelleted
nuclei were then lysed with 1 mL radioimmunoprecipitation assay (RIPA)
buffer and incubated for a further 15 min at 4 °C. Chromatin was sheared
using a Diagenode Bioruptor at 4 °C. Sheared chromatin was transferred to
1.5-mL microcentrifuge tubes and spun at 14,000 rpm (Eppendorf 5415R)
for 15 min at 4 °C to pellet debris. For each liver from n = 4 animals per time
point, duplicate ChIPs were performed with each antibody. ChIP-grade
antibodies were purchased from Abcam: anti-H3K4me3 (ab8580), anti-
H3K9me3 (ab8898), anti-histone H3 (ab1791), and anti-MLL3 (ab71200).
Fifty microliters of Protein G magnetic beads (Dynal/Invitrogen) were
washed three times and then incubated with 5 μg of antibody in 300-μL
volumes for 4 h at 4 °C on a rotator. Excess, or nonspeciﬁcally bound, an-
tibody was removed by washing a further three times in PBS/BSA. The
beads were then added to 900 μL of sheared chromatin in 1.5-mL DNA Lo-
bind tubes (Eppendorf) and incubated at 4 °C overnight with gentle rota-
tion. Beads were washed six times in 1 mL of LiCl Wash Buffer for 3 min
each, followed by a brief wash in Tris-EDTA (TE) buffer (pH 7.4). The beads
were then suspended in TE and transferred to a clean microcentrifuge tube,
and TE was removed. IP elution buffer (200 μL) was added at room tem-
perature, and then the beads were incubated for 45 min at 65 °C with
continuous shaking on a thermomixer (at 800 rpm). The eluate was then
removed from the beads and incubated overnight at 65 °C to reverse cross-
linking. DNA was extracted using a Qiagen Minelute PCR puriﬁcation kit
(using 12 μL of Buffer EB to elute DNA) and then quantiﬁed using Picogreen
assays (Invitrogen) in a microplate as per the manufacturer’s instructions.
Input chromatin was reverse–cross-linked in parallel and assayed with
a Nanodrop spectrophotometer (because of the much higher DNA con-
centration), and a sample was run on a 2% agarose gel to check fragment
size distributions were correct. See SI Appendix for further details.
Multiplex Library Preparation and Sequencing. For H3K4me3, H3K9me3, his-
tone H3, and input DNA samples, these were prepared for sequencing on an
Illumina Genome Analyzer II following the manufacturer’s recommended
library preparation protocol using 50 ng of chromatin-immunoprecipitated
DNA. All libraries were multiplexed, and four indexed pooled samples
(corresponding to four time points: CT0, -6, -12, -18) sequenced per lane. See
SI Appendix for further details.
Bioinformatics: Alignment and Peak Detection. Raw paired-end 50-bp reads (in
FASTQ format) were aligned to the University of California, Santa Cruz (UCSC)
mm9 genome build with Bowtie using prebuilt indexes downloaded from
the host website (29). Alignment ﬁles were then converted from the stan-
dard Bowtie output format to ALN ﬁles (for use with CisGenome) using
a custom Perl script. Alignments were then analyzed using a 2-sample
comparison (chromatin-immunoprecipitated sample vs. input control for
each time point) with CisGenome Version 1, using a cutoff false discovery
rate of 10% and a sliding window size of 100 (30). Output ﬁles were con-
verted into various formats for browsing datasets and to display data. The
CisGenome and UCSC browsers were used for data visualization, using cus-
tom tracks (31). Raw sequence data (FASTQ format), alignments (Bowtie
format), and peak data (as CisGenome/Affymetrix BAR format) have been
deposited in the GEO database (accessions nos. GSE23550 and GSE37396).
See SI Appendix for further details.
Microarrays. Total RNA was isolated from liver samples of C57/Bl6 mice over
a circadian time course as described previously (16). Per time point, n = 3
biological replicate samples were collected and processed individually. RNA
from each individual biological replicate sample was hybridized on an
Affymetrix mouse Gene ST1.0 microarray (GEO accession no. GSE37396),
using the manufacturer’s protocol. Microarray analysis was performed using
GeneSpring GX 11, with intensity values being normalized using the robust
multiarray average algorithm. See SI Appendix for further details.
Real-Time PCR for Gene Expression Analysis. RNA from individual livers (see
ChIP methods above) was extracted with TRIzol reagent (Invitrogen) and
puriﬁed with RNAeasy Mini Kits (Qiagen). Total RNA was then used for
reverse transcription via a High Capacity cDNA Archive Kit (Applied Bio-
systems). The resulting cDNA was then diluted 1:5 and used in duplicate 10-
μL PCR reactions according to the manufacturer’s protocol (TaqMan Gene
Expression Master Mix; Applied Biosystems) with validated TaqMan Gene
Expression Assays (Applied Biosystems), for Nr1d1, assay mm00520708_m1
and formPer2, assay mm00478113_m1. For control reactions, mouse β-actin
mRNA was ampliﬁed from the same samples. Real-time PCR was performed
with an ABI 7900HT (Applied Biosystems) system. See SI Appendix for
further details.
Gel Electrophoresis and Immunoblotting. Wild-type and mCry1−/− mCry2−/−
animals (C57BL/6 background, 12 wk old) were individually housed under
12-h light, 12-h dark cycles and constant temperature (21 ± 2 °C). Livers from
animals were harvested every 4 h over the 24-h cycle (ZT0, -4, -8, -12, -16, -20),
ﬂash-frozen and stored at −80 °C. Lysates were diluted with denaturing
lithium dodecyl sulfate sample buffer (Invitrogen) with 1:10 β-mercaptoe-
thanol to a ﬁnal protein concentration 2 μg·μL−1 and heated to 70 °C for
10 min before loading on gels. Ten micrograms of protein per lane were
loaded for immunoblotting. We used NuPAGE Novex 4–12% Bis-Tris gra-
dient gels for Bmal1 and β-actin analyses, and 3–8% Tris-acetate gels for
MLL3 (Life Technologies). Gels were run according to the manufacturer’s
protocol with a nonreducing Mes SDS buffer system (for Bis-Tris gels), or
Tris-acetate SDS buffer (for Tris-acetate gels). Protein transfer to nitrocel-
lulose for blotting was performed and the nitrocellulose was then washed
brieﬂy and then blocked for 30 min in 0.5% wt/wt BSA/nonfat dried milk
(Marvel) in Tris-buffered saline/0.05% Tween-20 (TBST). After three brief
washes in TBST, membranes were incubated in antibody diluted in blocking
buffer (0.5% milk/BSA) overnight at 4 °C. The following day, membranes
were washed for 5 min three times (in TBST) and then incubated with
1:10,000 HRP-conjugated secondary antibody (Sigma-Aldrich) for 30 min.
Four more 10-min washes were then performed before performing chem-
iluminescence detection. See SI Appendix for further details.
Bioluminescence Reporter Vectors. Promoter regions from mouse Bmal1 and
Per2 (30, 32) were ampliﬁed by PCR or digested directly from the parent vector
forCry1 (31, 33) and subcloned into thepGL4.20 vector (Promega) between the
KpnI and HindIII restriction enzyme sites. For Rev-erbα (Nr1d1), a 1,003-bp
fragment (mouse chromosome 11:98636454–98637456, mm9 annotation) was
ampliﬁed by PCR from BAC clone RP23-395E10 and then cloned into pGL4.20
using restriction-free cloning (16, 34). Clones were sequence-veriﬁed to con-
ﬁrm correct insert sequences. See SI Appendix for further details.
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Fig. 3. Histone methyltransferase activity of MLL3 is important for circadian
gene expression at the genomic scale. Heat maps showing H3K4me3- and
MLL3-binding signal at promoter regions in wild-type (MLL3+/+) or methyl-
transferase-deﬁcient (MLL3Δ/Δ) MEFs. Regions from –5 kb to +5 kb sur-
rounding the center of each binding site are shown. Each line represents an
H3K4me3- and MLL3-binding region. Time after dexamethasone (DEX)
synchronization is shown. The input (nonenriched) DNA signal at the same
locus is shown for comparison.
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Cell Culture and Bioluminescence Assays. Cells were cultured at 37 °C, 5% CO2
in a standard humidiﬁed incubator. To create stable luciferase reporter lines,
1 μg of each vector was transfected using GeneJuice Transfection Reagent
(catalog no. 70967-3; Novagen), and then cells selected for approximately
2 wk with puromycin-supplementedmedium (ﬁnal concentration of 2 μg·mL−1)
in 35-mm-diameter cell culture dishes. Bioluminescence assays were per-
formed at 37 °C using 96-well plate reader (CentroLIA LB 960; Berthold
Technologies), with an integration time of 56 s per well, every 90 min, using
a standard protocol (7, 35). See SI Appendix for further details.
Statistical Analysis. Parametric statistics (one- and two-way ANOVA) and χ2
tests were performed using Graphpad Prism Version 5 software.
ACKNOWLEDGMENTS. We thank J. Lee for sharing MEF cell lines. This work
was supported by the Wellcome Trust (083643/Z/07/Z), the European
Molecular Biology Organization Young Investigators Programme, the Med-
ical Research Council Centre for Obesity and Related metabolic Disorders,
and the National Institute for Health Research Cambridge Biomedical Re-
search Centre.
1. O’Neill JS, Reddy AB (2011) Circadian clocks in human red blood cells. Nature
469(7331):498–503.
2. O’Neill JS, et al. (2011) Circadian rhythms persist without transcription in a eukaryote.
Nature 469(7331):554–558.
3. Hogenesch JB, Ueda HR (2011) Understanding systems-level properties: Timely stories
from the study of clocks. Nat Rev Genet 12(6):407–416.
4. Bass J, Takahashi JS (2010) Circadian integration of metabolism and energetics. Sci-
ence 330(6009):1349–1354.
5. Reddy AB, et al. (2006) Circadian orchestration of the hepatic proteome. Curr Biol
16(11):1107–1115.
6. Panda S, et al. (2002) Coordinated transcription of key pathways in the mouse by the
circadian clock. Cell 109(3):307–320.
7. Hughes ME, et al. (2009) Harmonics of circadian gene transcription in mammals. PLoS
Genet 5(4):e1000442.
8. Ripperger JA, Schibler U (2006) Rhythmic CLOCK-BMAL1 binding tomultiple E-boxmotifs
drives circadian Dbp transcription and chromatin transitions. Nat Genet 38(3):369–374.
9. Katada S, Sassone-Corsi P (2010) The histone methyltransferase MLL1 permits the
oscillation of circadian gene expression. Nat Struct Mol Biol 17(12):1414–1421.
10. DiTacchio L, et al. (2011) Histone lysine demethylase JARID1a activates CLOCK-BMAL1
and inﬂuences the circadian clock. Science 333(6051):1881–1885.
Bmal1::luciferase
24 48 72 96 120 144
105000
108500
112000
TIme(h)
C
ou
nt
s/
se
c
MLL3 +/+
24 48 72 96 120 144
1250000
1300000
1350000
1400000
TIme(h)
C
ou
nt
s/
se
c
MLL3 /
mCry1::luciferase
24 48 72 96 120 144
850000
900000
950000
MLL3 +/+
TIme(h)
C
ou
nt
s/
se
c
24 48 72 96 120 144
380000
390000
400000
410000
420000
TIme(h)
C
ou
nt
s/
se
c
MLL3 /
mPer2::luciferase
24 48 72 96 120 144
150000
200000
250000
MLL3 +/+
TIme(h)
C
ou
nt
s/
se
c
24 48 72 96 120 144
145000
150000
155000
160000
165000
TIme(h)
C
ou
nt
s/
se
c
MLL3 /
Rev-erb ::luciferase
24 48 72 96 120 144
115000
120000
125000
130000
135000
140000
TIme(h)
C
ou
nt
s/
se
c
MLL3 +/+
24 48 72 96 120 144
100000
110000
120000
TIme(h)
C
ou
nt
s/
se
c
MLL3 /
CT0
CT6
CT12
CT18
Bmal1mPer1 mPer2 mCry1 mCry2Rev-erb
D
ay
N
ight
CT0
A B 
C mPer2 Pre-mRNA
48 54 60 66 72 78
0
50
100
150
R
el
. g
en
e 
ex
pr
es
si
on
Rev-erb  Pre-mRNA
Time after DEX treatment (h)
R
el
. g
en
e 
ex
pr
es
si
on
48 54 60 66 72 78
0
50
100
150
mPer2 mRNA
48 54 60 66 72 78
0
50
100
150
Rev-erb mRNA
Time after DEX treatment (h)
48 54 60 66 72 78
0
50
100
150
MLL3 +/+
MLL3 /
***
***
**
**
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